Sunshine Biopharma, Inc. (NASDAQ:SBFM) Short Interest Update

Posted by Jeff Wilder on Jul 12th, 2024

Sunshine Biopharma, Inc. (NASDAQ:SBFM – Get Free Report) saw a significant decline in short interest in June. As of June 30th, there was short interest totalling 852,200 shares, a decline of 45.7% from the June 15th total of 1,570,000 shares. Based on an average daily volume of 4,240,000 shares, the days-to-cover ratio is currently 0.2 days. Currently, 3.7% of the shares of the stock are sold short.

Institutional Investors Weigh In On Sunshine Biopharma

An institutional investor recently raised its position in Sunshine Biopharma stock. Armistice Capital LLC lifted its holdings in Sunshine Biopharma, Inc. (NASDAQ:SBFM – Free Report) by 118.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,130,000 shares of the company’s stock after acquiring an additional 1,156,000 shares during the quarter. Armistice Capital LLC owned approximately 8.29% of Sunshine Biopharma worth $578,000 at the end of the most recent reporting period. 41.98% of the stock is owned by institutional investors and hedge funds.

Sunshine Biopharma Stock Performance

NASDAQ SBFM traded down $0.01 during trading on Friday, reaching $0.33. 757,509 shares of the company traded hands, compared to its average volume of 2,188,311. The stock’s 50 day moving average price is $0.58 and its two-hundred day moving average price is $8.71. The company has a market cap of $7.75 million, a price-to-earnings ratio of -0.03 and a beta of 1.42. Sunshine Biopharma has a 1-year low of $0.28 and a 1-year high of $64.50.

Sunshine Biopharma (NASDAQ:SBFM – Get Free Report) last released its quarterly earnings data on Monday, May 20th. The company reported ($2.00) earnings per share for the quarter. The company had revenue of $7.54 million for the quarter. Sunshine Biopharma had a negative net margin of 15.29% and a negative return on equity of 17.95%.

Sunshine Biopharma Company Profile

(Get Free Report)

Sunshine Biopharma, Inc, a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates in two segments, Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products.